We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies.
Astraveus has raised €27M across 2 funding rounds from 5 investors, most recently a Grant round in Oct 2023. Based in Paris, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2023-10-24 | Grant | €10M | French Government | View deal → |
| 2023-06-29 | Seed | €17M | AdBio partners,Bpifrance,JJDC – Johnson & Johnson's fund,M Ventures | View deal → |
